benidipine has been researched along with Disease Models, Animal in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Albayrak, A; Arslan, R; Bayraktar, M; Bekmez, H; Çelik, M; Kaya, Z; Koçak, MN; Tavaci, T; Tekin, E | 1 |
| Kazama, I | 1 |
| Akhtar, M; Akhtar, MS; Ali, J; Ansari, SH; Haque, SE; Hassan, MQ; Najmi, AK | 1 |
| Baba, A; Ejima, Y; Endo, Y; Kazama, I; Matsubara, M; Toyama, H | 1 |
| Furuta, K; Hongo, M; Ishizaka, N; Koike, K; Matsuzaki, G; Nagai, R; Saito, K; Sakamoto, A; Sakurai, R | 1 |
| Kitakaze, M; Liao, YL; Luo, Q; Xi, F; Xuan, WL | 1 |
| Furusho, H; Kaneko, S; Kitano, K; Ohtani, K; Okajima, M; Takamura, M; Takashima, S; Usui, S; Yamamoto, K | 1 |
| Hattori, Y; Jesmin, S; Kitabatake, A; Miyauchi, T; Sakuma, I | 1 |
| Ikeda, J; Matsubara, M; Yao, K | 1 |
| Arakawa, E; Hasegawa, K; Ina, Y; Matsubara, M; Takada, C; Takayama, M; Yao, K | 1 |
| Karasawa, A; Yao, K | 1 |
| Hara, T; Ishi, A; Shuto, K; Ueno, H | 1 |
| Kawachi, H; Nakamura, T; Obata, JE; Onitsuka, M; Shimada, Y; Shimizu, F; Yoshida, Y | 1 |
| Fujii, S; Hattori, Y; Jesmin, S; Kitabatake, A; Sakuma, I | 1 |
1 review(s) available for benidipine and Disease Models, Animal
| Article | Year |
|---|---|
Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Disease Progression; Electrophysiological Phenomena; Humans; Immunologic Factors; Kidney; Kv1.3 Potassium Channel; Leukocytes; Macrolides; Membrane Potentials; Renal Insufficiency, Chronic; T-Lymphocytes | 2015 |
14 other study(ies) available for benidipine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
An antihypertensive agent benidipine is an effective neuroprotective and antiepileptic agent: an experimental rat study.
Topics: Animals; Anticonvulsants; Antihypertensive Agents; Brain; Dihydropyridines; Disease Models, Animal; Male; Neuroprotective Agents; Rats; Rats, Wistar; Valproic Acid | 2021 |
Benidipine prevents oxidative stress, inflammatory changes and apoptosis related myofibril damage in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Cytoprotection; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Inflammation Mediators; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Myofibrils; Oxidative Stress; Rats, Wistar; Time Factors | 2015 |
Benidipine suppresses in situ proliferation of leukocytes and slows the progression of renal fibrosis in rat kidneys with advanced chronic renal failure.
Topics: Animals; Blood Urea Nitrogen; Calcium Channel Blockers; Cell Proliferation; Creatinine; Cytokines; Dihydropyridines; Disease Models, Animal; Disease Progression; Fibrosis; Kidney; Kidney Failure, Chronic; Kv1.3 Potassium Channel; Leukocytes; Male; Nephrectomy; Rats; Rats, Sprague-Dawley | 2014 |
Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome.
Topics: AMP-Activated Protein Kinases; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Channel Blockers; Carnitine O-Palmitoyltransferase; Cholesterol; Dihydropyridines; Disease Models, Animal; Kidney; Lipid Metabolism; Losartan; Male; Metabolic Syndrome; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Superoxides; Triglycerides | 2010 |
[Antihypertrophic effect of dihydropyridines calcium channel blockers is dependent on their potential of blocking N-type calcium channel].
Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Cardiomegaly; Dihydropyridines; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Nifedipine | 2010 |
Benidipine reduces ischemia reperfusion-induced systemic oxidative stress through suppression of aldosterone production in mice.
Topics: Aldosterone; Animals; Apoptosis; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Down-Regulation; Hemodynamics; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidative Stress; Ventricular Dysfunction, Left | 2012 |
The calcium channel antagonist benidipine reduces plasma and cardiac endothelin-1 levels in type II diabetic rat model.
Topics: Age Factors; Animals; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Dihydropyridines; Disease Models, Animal; Down-Regulation; Endothelin-1; Insulin Resistance; Male; Myocardium; Rats; Rats, Inbred OLETF; Rats, Long-Evans | 2004 |
Effects of benidipine in a rat model for experimental angina.
Topics: Amlodipine; Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Male; Nifedipine; Nitrophenols; Organophosphorus Compounds; Rats; Rats, Inbred Strains | 2006 |
Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
Topics: Animals; Aorta, Thoracic; Atherosclerosis; Calcium Channel Blockers; Cholesterol; Dihydropyridines; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperplasia; Male; Pravastatin; Rabbits; RNA, Messenger; Scavenger Receptors, Class E; Time Factors; Tunica Intima; Up-Regulation; Vascular Cell Adhesion Molecule-1; Vasodilation | 2007 |
Protective effects of benidipine against myocardial damage following ischemia and reperfusion in the isolated perfused rat heart.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Thromboxane A2; Vascular Resistance; Vasoconstrictor Agents | 1994 |
Effects of benidipine hydrochloride on cerebrovascular lesions in salt-loaded stroke-prone spontaneously hypertensive rats: evaluation by magnetic resonance imaging.
Topics: Analysis of Variance; Animals; Blood Pressure; Body Weight; Brain; Cerebrovascular Disorders; Dihydropyridines; Disease Models, Animal; Magnetic Resonance Imaging; Male; Psychomotor Performance; Rats; Rats, Inbred SHR; Sodium Chloride, Dietary; Vasodilator Agents | 2000 |
Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Topics: Actins; Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Creatinine; Dihydropyridines; Disease Models, Animal; Disease Progression; Fluorescent Antibody Technique; Glomerulonephritis, Membranoproliferative; Hydralazine; Kidney Failure, Chronic; Kidney Glomerulus; Male; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Transforming Growth Factor beta; Vasodilator Agents | 2000 |
Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model.
Topics: Animals; Calcium Channel Blockers; Capillaries; Collagen; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dihydropyridines; Disease Models, Animal; Endothelial Growth Factors; Fibroblast Growth Factor 2; Gene Expression Regulation; Lymphokines; Male; Neovascularization, Pathologic; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Inbred Strains; RNA, Messenger; Species Specificity; Transcription, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |